**Online Registration Closing 8:00 PM on Monday, September 14th.

Please Note: Walk-in registration will be available beginning at 8:00 AM on the morning of the symposium, as space allows.

Overview

One‑of‑a‑Kind Partnership
The Gene Therapy Initiative at UC San Diego, California Life Sciences and CIRM converge in La Jolla, CA – September 16 & 17 to discuss the Future of Cell & Gene Therapy.

All‑Encompassing Agendas

Day 1, hosted by UC San Diego GTI, features academic and industry leaders showcasing cutting‑edge cell‑based safety models, ex‑vivo and in‑vivo genetic therapy technologies, and bold bench‑to‑bedside strategies.
Day  2, hosted by CLS and CIRM, features panels on scientific innovation, manufacturing, patient delivery, and commercialization.

Tailored Flexibility
Each day stands on its own, so participants can choose to attend one or attend both. The program is built for everyone working in this space across Southern California, across therapeutics, manufacturing, research, capital, and the legal and policy infrastructure that supports the field.

Who Should Attend:

Academic researchers and post‑doctoral fellows in cell & gene therapy
Biotech and pharmaceutical scientists, project managers, and business development professionals
Investors, venture‑capital partners, entrepreneurs, and industry consultants
Regulatory affairs, quality & manufacturing specialists

Day 1 | Gene Therapy Initiative
Wednesday - September 16, 2026

Questions? Contact us at GTI_admin@health.ucsd.edu or (858) 534‑5207

Featuring:

Day 2 | California Life Sciences x CIRM
Thursday - September 17, 2026

Programming will cover topics including: Rare Disease and Regulatory Updates ● Advances in Gene Editing ● Commercialization and Manufacturing ● Patient Access